Clinical trials
Phase 1 Diabetes Mellitus, Type 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 8 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Novo Nordisk A/S | 7 |
| GlaxoSmithKline | 6 |
| Sirtris, a GSK Company | 5 |
| Eli Lilly and Company | 2 |
| Sanofi | 2 |
| Solvay Pharmaceuticals | 2 |
| Alizé Pharma | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Genmedica Therapeutics S.L. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 38 |
| Diabetes Mellitus | 11 |
| Diabetes Mellitus, Type 1 | 2 |
| Obesity | 2 |
| Atherosclerosis | 1 |
| Fatty Liver | 1 |
| Insulin Resistance | 1 |
| Kidney Diseases | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Overweight | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.